Abstract

Some pathogens are capable of suppressing the melanization response of host insects, but the virulence factors responsible are largely unknown. The insect pathogen Microplitis demolitor bracovirus encodes the Egf family of small serine proteinase inhibitors. One family member, Egf1.0, was recently shown to suppress melanization of hemolymph in Manduca sexta in part by inhibiting the enzymatic activity of prophenoloxidase activating proteinase 3 (PAP3). However, other experiments suggested this viral protein suppresses melanization by more than one mechanism. Here we report that Egf1.0 inhibited the amidolytic activity of PAP1 and dose-dependently blocked processing of pro-PAP1 and pro-PAP3. Consistent with its PAP inhibitory activity, Egf1.0 also prevented processing of pro-phenoloxidase, serine proteinase homolog (SPH) 1, and SPH2. Isolation of Egf1.0-protein complexes from plasma indicated that Egf1.0 binds PAPs through its C-terminal repeat domain. Egf1.0 also potentially interacts with SPH2 and two other proteins, ferritin and gloverin, not previously associated with the phenoloxidase cascade. Overall, our results indicate that Egf1.0 is a dual activity PAP inhibitor that strongly suppresses the insect melanization response.

Highlights

  • Bial elicitors [3, 4], a downstream proteinase (HP21) activated by HP14, and three terminal PAPs (PAP1, 2, 3) that cleave pro-PO at its Arg-Phe reactive site bond to form PO

  • Egf1.0 Inhibits the Amidolytic Activity of PAP1—As previously noted, PAPs purified from M. sexta hemolymph are already activated and, fully functional to hydrolyze synthetic substrates like IEARpNA

  • As found for prophenoloxidase activating proteinase 3 (PAP3) [26], the alanine replacement mutant Egf10R51A had no inhibitory activity toward PAP1, indicating the reactive site arginine in the CD was essential for inhibitory activity (Fig. 1)

Read more

Summary

Viral Melanization Inhibitor

Reactive site (LCYR2FQQF) in the CD, whereas Egf0.4 exhibits no PAP3 inhibitory activity even though its reactive site (FCFK2FTTV) is similar. Retains the ability to inhibit melanization of M. sexta plasma. Egf1.0⌬RD, which consists of only the CD, retains some antiamidolytic activity toward PAP3 but lacks anti-melanization activity in plasma [26]. Neither wild-type Egf1.0 nor any Egf1.0 mutants have any inhibitory effect on melanization once PO is activated [26]. Taken together, these data indicate that Egf1.0 disables hemolymph melanization in M. sexta in part by competitively inhibiting the enzymatic activity of PAP3. The ability of Egf1.0R51A and Egf1.0⌬CD to inhibit melanization but not the amidolytic activity of PAP3 suggests that Egf1.0 disrupts the melanization process by more than one mechanism. Our results reveal that Egf1.0 inhibits processing of pro-PAP1 and pro-PAP3

EXPERIMENTAL PROCEDURES
RESULTS
His tag and potential interacting proteins by adding the samples to
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call